5-Bromo-6-chloro-4-methylpyridin-3-amine, 95.0%, 50mg

Adamantane, min.99%, pour la synthèse, 100 g, emballage en verre

(S)-2-Amino-N-(4-methyl-2-oxo-2H-chromen-7-yl)propanamide, 95.0%, 250mg

4,5-Dichloroindoline-2,3-dione, 95.0%, 5g

2,4-Difluorobenzylamine, 99.0%, 25g

5-Hydrazinyl-2-methoxypyridine hydrochloride, 95.0%, 1g

5-Methyl-2-(trifluoromethyl)benzonitrile, 95.0%, 5g

Methyl 1-chloroisoquinoline-7-carboxylate, 98%, 250mg

Ethyl 3-bromo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyridine-6-carboxylate, 97%, 250mg

Ethyl 7-oxononanoate, 97.0%, 1g

3-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl chloride, 95.0%, 1g

3-Nitro-4-(trifluoromethoxy)phenylboronic acid, 97%, 10g

4-Fluoro-3-(trifluoromethyl)benzenesulfonyl Chloride>98.0%(GC)5g